NON ALCOHOLIC STEATOHEPATITIS (NASH) THERAPEUTICS AND DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market, By Therapeutics (Elafibranor, Ocaliva, Selonsertib, Cenicriviroc, Emricasan, and Other Therapeutics), By Diagnostics (Imaging Techniques, Diagnostic Tests, and Biopsy), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)-

Published In: 28 Apr, 2026
Code: CMI2279
Page number: 170
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026):

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Therapeutics
  - Market Snapshot, By Diagnostics
  - Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rise in NASH-affected population worldwide
  - Slow advancements in the therapeutic field
  - Rise in demand for safe/effective therapeutics and diagnostics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market, By Therapeutics, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Elafibranor
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Ocaliva
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Selonsertib
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Cenicriviroc
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Emricasan
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Therapeutics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Global Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market, By Diagnostics, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Imaging Techniques
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Diagnostic Tests
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Biopsy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Global Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East and Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Rest of World
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Competitive Landscape
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Allergan Plc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Viking Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Zydus Cadila
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GENFIT SA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gilead Sciences Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Galmed Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Madrigal Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Intercept Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
  - Analyst Views
Section
- Research Methodology
- About us

*Browse 24 market data tables and 28 figures on "Global Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market” - forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now